Predictive Value of HAS-BLED and HEMORR2HAGES Bleeding Risk Scores After Percutaneous Coronary Intervention.

Autor: Doomun I; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Doomun D; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Schukraft S; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Arroyo D; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Cook ST; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Huwyler T; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Goy JJ; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Stauffer JC; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Togni M; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Puricel S; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland., Cook S; Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland.
Jazyk: angličtina
Zdroj: Texas Heart Institute journal [Tex Heart Inst J] 2024 Jul 10; Vol. 51 (2).
DOI: 10.14503/THIJ-23-8267
Abstrakt: Background: Various scoring systems have been developed to assess the risk of bleeding in medical settings. HAS-BLED and HEMORR2HAGES risk scores are commonly used to estimate bleeding risk in patients receiving anticoagulation for atrial fibrillation, but data on their predictive value in patients undergoing percutaneous coronary intervention (PCI) are limited.
Methods: This study evaluated and compared the predictive abilities of the HAS-BLED and HEMORR2HAGES bleeding risk scores in all-comer patients undergoing PCI. The PARIS score, specifically designed for patients undergoing PCI, was used as a comparator. The scores were calculated at baseline and compared with the occurrence of events during a 2-year clinical follow-up period. Between 2015 and 2017, all consecutive patients undergoing PCI we re prospectively enrolled and divided into risk tertiles based on bleeding risk scores. The primary end points were hierarchical major bleeding events, defined by Bleeding Academic Research Consortium types 3 through 5, and patient-oriented composite end points according to Bleeding Academic Research Consortium classification, which were assessed during the 2-year follow-up period.
Results: A total of 1,080 patients completed the follow-up period. Two years after index, 189 patients (17.5%) had experienced any bleeding, with 48 events (4.4%) classified as Bleeding Academic Research Consortium types 3 to 5. All bleeding risk scores showed statistically significant predictive ability for bleeding events. The HEMORR2HAGES score (C statistic, 0.73) was more effective than the HAS-BLED score (C statistic, 0.66; P = .07) and the PARIS score (C statistic, 0.66; P = .06) in predicting risk of major bleeding. Patients in high-risk bleeding groups also experienced a higher incidence of patient-oriented composite end points.
Conclusions: The HEMORR2HAGES, HAS-BLED, and PARIS risk scores exhibited good predictive abilities for bleeding events following PCI. Patients at high risk of bleeding also demonstrated increased ischemic risk and higher mortality during the 2-year follow-up period.
(© 2024 The Authors. Published by The Texas Heart Institute®.)
Databáze: MEDLINE
Externí odkaz: